Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.

D-0736-2022

March 17, 2022

Class II

Product summary

Firm
Aurolife Pharma, LLC
Event
Event 89869
Status
Terminated
Classification
Class II
Quantity
4080 bottles
Official record key
drug-enforcement:D-0736-2022

Official wording

Reason: Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Code information: Lot: 01421008A1, Exp 03/2023

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Substance